메뉴 건너뛰기




Volumn 97, Issue 2, 2016, Pages 150-158

Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma

Author keywords

biomarker targeted therapy; epithelial ovarian cancer; immunohistochemistry; independent prognostic marker; TROP2

Indexed keywords

MEMBRANE ANTIGEN; MESSENGER RNA; TROPHOBLAST CELL SURFACE ANTIGEN 2; TUMOR ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

EID: 84977498804     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/iep.12174     Document Type: Article
Times cited : (24)

References (36)
  • 1
    • 0035008525 scopus 로고    scopus 로고
    • Ovarian surface epithelium: biology, endocrinology, and pathology
    • &, –
    • Auersperg N., Wong A.S., Choi K.C., Kang S.K. & Leung P.C. (2001) Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr. Rev. 22, 255–288.
    • (2001) Endocr. Rev. , vol.22 , pp. 255-288
    • Auersperg, N.1    Wong, A.S.2    Choi, K.C.3    Kang, S.K.4    Leung, P.C.5
  • 2
    • 84859169877 scopus 로고    scopus 로고
    • The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
    • Barretina J., Caponigro G., Stransky N. et al. (2012) The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483, 603–607.
    • (2012) Nature , vol.483 , pp. 603-607
    • Barretina, J.1    Caponigro, G.2    Stransky, N.3
  • 3
    • 80052014052 scopus 로고    scopus 로고
    • Inflammation meets cancer, with NF- κB as the matchmaker
    • &, –
    • Ben-Neriah Y. & Karin M. (2011) Inflammation meets cancer, with NF- κB as the matchmaker. Nat. Immunol. 12, 715–723.
    • (2011) Nat. Immunol. , vol.12 , pp. 715-723
    • Ben-Neriah, Y.1    Karin, M.2
  • 4
    • 77349099069 scopus 로고    scopus 로고
    • Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients
    • Bignotti E., Todeschini P., Calza S. et al. (2010) Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. Eur. J. Cancer 46, 944–953.
    • (2010) Eur. J. Cancer , vol.46 , pp. 944-953
    • Bignotti, E.1    Todeschini, P.2    Calza, S.3
  • 5
    • 19744368302 scopus 로고    scopus 로고
    • Cancer of the ovary
    • Cannistra S.A. (2004) Cancer of the ovary. N. Engl. J. Med. 351, 2519–2529.
    • (2004) N. Engl. J. Med. , vol.351 , pp. 2519-2529
    • Cannistra, S.A.1
  • 6
    • 84930199314 scopus 로고    scopus 로고
    • Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2/SN-38 Antibody-Drug Conjugate: Characterization and Efficacy in Pancreatic, Gastric, and Other Cancers
    • Cardillo TM, Govindan SV, Sharkey RM et al. (2015) Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2/SN-38 Antibody-Drug Conjugate: Characterization and Efficacy in Pancreatic, Gastric, and Other Cancers. Bioconjug. Chem. 26, 919–931.
    • (2015) Bioconjug. Chem. , vol.26 , pp. 919-931
    • Cardillo, T.M.1    Govindan, S.V.2    Sharkey, R.M.3
  • 7
    • 51649112174 scopus 로고    scopus 로고
    • Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention
    • Carlson J.W., Miron A., Jarboe E.A. et al. (2008) Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention. J. Clin. Oncol. 26, 4160–4165.
    • (2008) J. Clin. Oncol. , vol.26 , pp. 4160-4165
    • Carlson, J.W.1    Miron, A.2    Jarboe, E.A.3
  • 8
    • 84875690627 scopus 로고    scopus 로고
    • Latest research and treatment of advanced-stage epithelial ovarian cancer
    • &, –
    • Coleman R.L., Monk B.J., Sood A.K. & Herzog T.J. (2013) Latest research and treatment of advanced-stage epithelial ovarian cancer. Nat. Rev. Clin. Oncol. 10, 211–224.
    • (2013) Nat. Rev. Clin. Oncol. , vol.10 , pp. 211-224
    • Coleman, R.L.1    Monk, B.J.2    Sood, A.K.3    Herzog, T.J.4
  • 9
    • 63549123345 scopus 로고    scopus 로고
    • Intercepting pelvic cancer in the distal fallopian tube: theories and realities
    • Crum C.P. (2009) Intercepting pelvic cancer in the distal fallopian tube: theories and realities. Mol Oncol 3, 165–170.
    • (2009) Mol Oncol , vol.3 , pp. 165-170
    • Crum, C.P.1
  • 10
    • 70349175559 scopus 로고    scopus 로고
    • Trop2: a possible therapeutic target for late stage epithelial carcinomas
    • &, –
    • Cubas R., Li M., Chen C. & Yao Q. (2009) Trop2: a possible therapeutic target for late stage epithelial carcinomas. Biochim. Biophys. Acta 1796, 309–314.
    • (2009) Biochim. Biophys. Acta , vol.1796 , pp. 309-314
    • Cubas, R.1    Li, M.2    Chen, C.3    Yao, Q.4
  • 11
    • 77956671612 scopus 로고    scopus 로고
    • Trop2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway
    • &
    • Cubas R., Zhang S., Li M., Chen C. & Yao Q. (2010) Trop2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway. Mol. Cancer. 9, 253.
    • (2010) Mol. Cancer. , vol.9 , pp. 253
    • Cubas, R.1    Zhang, S.2    Li, M.3    Chen, C.4    Yao, Q.5
  • 12
    • 67649460732 scopus 로고    scopus 로고
    • Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer
    • Fang Y.J., Lu Z.H., Wang G.Q. et al. (2009) Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer. Int. J. Colorectal Dis. 24, 875–884.
    • (2009) Int. J. Colorectal Dis. , vol.24 , pp. 875-884
    • Fang, Y.J.1    Lu, Z.H.2    Wang, G.Q.3
  • 13
    • 84876207877 scopus 로고    scopus 로고
    • Recurrent epithelial ovarian cancer: an update on treatment
    • &, –, 298
    • Foley O.W., Rauh-Hain J.A. & del Carmen M.G. (2013) Recurrent epithelial ovarian cancer: an update on treatment. Oncology (Williston Park). 27, 288–294 298.
    • (2013) Oncology (Williston Park). , vol.27 , pp. 288-294
    • Foley, O.W.1    Rauh-Hain, J.A.2    del Carmen, M.G.3
  • 14
    • 38649112304 scopus 로고    scopus 로고
    • TROP2: a novel prognostic marker in squamous cell carcinoma of the oral cavity
    • Fong D., Spizzo G., Gostner J.M. et al. (2008a) TROP2: a novel prognostic marker in squamous cell carcinoma of the oral cavity. Mod. Pathol. 21, 186–191.
    • (2008) Mod. Pathol. , vol.21 , pp. 186-191
    • Fong, D.1    Spizzo, G.2    Gostner, J.M.3
  • 15
    • 53849132678 scopus 로고    scopus 로고
    • High expression of TROP2 correlates with poor prognosis in pancreatic cancer
    • Fong D., Moser P., Krammel C. et al. (2008b) High expression of TROP2 correlates with poor prognosis in pancreatic cancer. Br. J. Cancer 99, 1290–1295.
    • (2008) Br. J. Cancer , vol.99 , pp. 1290-1295
    • Fong, D.1    Moser, P.2    Krammel, C.3
  • 16
    • 0029146211 scopus 로고
    • Cloning of the gene encoding Trop-2, a cell-surface glycoprotein expressed by human carcinomas
    • Fornaro M., Dell'Arciprete R., Stella M. et al. (1995) Cloning of the gene encoding Trop-2, a cell-surface glycoprotein expressed by human carcinomas. Int. J. Cancer 62, 610–618.
    • (1995) Int. J. Cancer , vol.62 , pp. 610-618
    • Fornaro, M.1    Dell'Arciprete, R.2    Stella, M.3
  • 17
    • 84941253818 scopus 로고    scopus 로고
    • Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC)
    • Goldenberg D.M., Cardillo T.M., Govindan S.V. et al. (2015) Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC). Oncotarget. 6, 22496–22512.
    • (2015) Oncotarget. , vol.6 , pp. 22496-22512
    • Goldenberg, D.M.1    Cardillo, T.M.2    Govindan, S.V.3
  • 18
    • 12144291260 scopus 로고    scopus 로고
    • Preclinical therapy of breast cancer with a radioiodinated humanized anti-EGP-1 monoclonal antibody: advantage of a residualizing iodine radiolabel
    • Govindan S.V., Stein R., Qu Z. et al. (2004) Preclinical therapy of breast cancer with a radioiodinated humanized anti-EGP-1 monoclonal antibody: advantage of a residualizing iodine radiolabel. Breast Cancer Res. Treat. 84, 173–182.
    • (2004) Breast Cancer Res. Treat. , vol.84 , pp. 173-182
    • Govindan, S.V.1    Stein, R.2    Qu, Z.3
  • 19
    • 0036107889 scopus 로고    scopus 로고
    • Discovery of novel tumor markers of pancreatic cancer using global gene expression technology
    • Iacobuzio-Donahue C.A., Maitra A., Shen-Ong G.L. et al. (2002) Discovery of novel tumor markers of pancreatic cancer using global gene expression technology. Am. J. Pathol. 160, 1239–1249.
    • (2002) Am. J. Pathol. , vol.160 , pp. 1239-1249
    • Iacobuzio-Donahue, C.A.1    Maitra, A.2    Shen-Ong, G.L.3
  • 20
    • 0028280630 scopus 로고
    • Glucocorticoids stabilize HER-2/neu messenger RNA in human epithelial ovarian carcinoma cells
    • Karlan B.Y., Jones J., Slamon D.J. et al. (1994) Glucocorticoids stabilize HER-2/neu messenger RNA in human epithelial ovarian carcinoma cells. Gynecol. Oncol. 53, 70–77.
    • (1994) Gynecol. Oncol. , vol.53 , pp. 70-77
    • Karlan, B.Y.1    Jones, J.2    Slamon, D.J.3
  • 21
    • 34547205231 scopus 로고    scopus 로고
    • Resistance to chemotherapy in ovarian carcinoma: recent results
    • Lage H., Denkert C. (2007) Resistance to chemotherapy in ovarian carcinoma: recent results. Cancer Res. 176, 51–60.
    • (2007) Cancer Res. , vol.176 , pp. 51-60
    • Lage, H.1    Denkert, C.2
  • 22
    • 84870953959 scopus 로고    scopus 로고
    • Significantly upregulated TACSTD2 and Cyclin D1 correlate with poor prognosis of invasive ductal breast cancer
    • Lin H., Huang J.F., Qiu J.R. et al. (2012) Significantly upregulated TACSTD2 and Cyclin D1 correlate with poor prognosis of invasive ductal breast cancer. Exp. Mol. Pathol. 94, 73–78.
    • (2012) Exp. Mol. Pathol. , vol.94 , pp. 73-78
    • Lin, H.1    Huang, J.F.2    Qiu, J.R.3
  • 23
    • 0019780296 scopus 로고
    • Human trophoblast cell-surface antigens defined by monoclonal antibodies
    • &, –
    • Lipinski M., Parks D.R., Rouse R.V. & Herzenberg L.A. (1981) Human trophoblast cell-surface antigens defined by monoclonal antibodies. Proc. Natl Acad. Sci. USA 78, 5147–5150.
    • (1981) Proc. Natl Acad. Sci. USA , vol.78 , pp. 5147-5150
    • Lipinski, M.1    Parks, D.R.2    Rouse, R.V.3    Herzenberg, L.A.4
  • 24
    • 0026808859 scopus 로고
    • Simian virus 40- transformed human ovarian surface epithelial cells escape normal growth controls but retain morphogenetic responses to extracellular matrix
    • &, –
    • Maines-Bandiera S., Kruk P. & Auersperg N. (1992) Simian virus 40- transformed human ovarian surface epithelial cells escape normal growth controls but retain morphogenetic responses to extracellular matrix. Am. J. Obstet. Gynecol. 167, 729–735.
    • (1992) Am. J. Obstet. Gynecol. , vol.167 , pp. 729-735
    • Maines-Bandiera, S.1    Kruk, P.2    Auersperg, N.3
  • 25
    • 14844346661 scopus 로고    scopus 로고
    • Protection of platinum-DNA adduct formation and reversal of cisplatin resistance by anti-MRP2 hammerhead ribozymes in human cancer cells
    • Materna V., Liedert B., Thomale J., Lage H. (2005) Protection of platinum-DNA adduct formation and reversal of cisplatin resistance by anti-MRP2 hammerhead ribozymes in human cancer cells. Int. J. Cancer 115, 393–402.
    • (2005) Int. J. Cancer , vol.115 , pp. 393-402
    • Materna, V.1    Liedert, B.2    Thomale, J.3    Lage, H.4
  • 28
    • 0031800858 scopus 로고    scopus 로고
    • Human Trop-2 is a tumor-associated calcium signal transducer
    • &, –
    • Ripani E., Sacchetti A., Corda D. & Alberti S. (1998) Human Trop-2 is a tumor-associated calcium signal transducer. Int. J. Cancer 76, 671–676.
    • (1998) Int. J. Cancer , vol.76 , pp. 671-676
    • Ripani, E.1    Sacchetti, A.2    Corda, D.3    Alberti, S.4
  • 29
    • 80051580618 scopus 로고    scopus 로고
    • Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths
    • &, –
    • Siegel R., Ward E., Brawley O. & Jemal A. (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J. Clin. 61, 212–236.
    • (2011) CA Cancer J. Clin. , vol.61 , pp. 212-236
    • Siegel, R.1    Ward, E.2    Brawley, O.3    Jemal, A.4
  • 30
    • 84930220109 scopus 로고    scopus 로고
    • First-in-Human trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the treatment of diverse metastatic solid tumors
    • Starodub A.N., Ocean A.J., Shah M.A. et al. (2015) First-in-Human trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the treatment of diverse metastatic solid tumors. Clin. Cancer Res. 21, 3870–3878.
    • (2015) Clin. Cancer Res. , vol.21 , pp. 3870-3878
    • Starodub, A.N.1    Ocean, A.J.2    Shah, M.A.3
  • 31
    • 77955800063 scopus 로고    scopus 로고
    • (-)-Epigallocatechin-3-gallate (EGCG) post-transcriptionally and post-translationally suppresses the cell proliferative protein TROP2 in human colorectal cancer cells
    • &, –
    • Sukhthankar M., Alberti S. & Baek S.J. (2010) (-)-Epigallocatechin-3-gallate (EGCG) post-transcriptionally and post-translationally suppresses the cell proliferative protein TROP2 in human colorectal cancer cells. Anticancer Res. 30, 2497–2503.
    • (2010) Anticancer Res. , vol.30 , pp. 2497-2503
    • Sukhthankar, M.1    Alberti, S.2    Baek, S.J.3
  • 32
    • 84921652721 scopus 로고    scopus 로고
    • Inhibition of microtubule-associated protein1 light chain 3B via small-interfering RNA or 3-methyladenine impairs hypoxia-induced HO8910PM and HO8910 epithelial ovarian cancer cell migration and invasion and is associated with RhoA and alterations of the actin cytoskeleton
    • Tang Z., Zhang N., Di W. et al. (2015) Inhibition of microtubule-associated protein1 light chain 3B via small-interfering RNA or 3-methyladenine impairs hypoxia-induced HO8910PM and HO8910 epithelial ovarian cancer cell migration and invasion and is associated with RhoA and alterations of the actin cytoskeleton. Oncol. Rep. 33, 1411–1417.
    • (2015) Oncol. Rep. , vol.33 , pp. 1411-1417
    • Tang, Z.1    Zhang, N.2    Di, W.3
  • 33
    • 79960024794 scopus 로고    scopus 로고
    • Uterine serous papillary carcinomas overexpress human trophoblast-cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized anti-Trop-2 monoclonal antibody
    • Varughese J., Cocco E., Bellone S. et al. (2011) Uterine serous papillary carcinomas overexpress human trophoblast-cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized anti-Trop-2 monoclonal antibody. Cancer 117, 3163–3172.
    • (2011) Cancer , vol.117 , pp. 3163-3172
    • Varughese, J.1    Cocco, E.2    Bellone, S.3
  • 34
    • 33645284166 scopus 로고    scopus 로고
    • Cetuximab and irinotecan as thirdline therapy in advanced colorectal cancer patients: a single centre phase II trial
    • Vincenzi B., Santini D., Rabitti C. et al. (2006) Cetuximab and irinotecan as thirdline therapy in advanced colorectal cancer patients: a single centre phase II trial. Br. J. Cancer 94, 792–797.
    • (2006) Br. J. Cancer , vol.94 , pp. 792-797
    • Vincenzi, B.1    Santini, D.2    Rabitti, C.3
  • 35
    • 39749154101 scopus 로고    scopus 로고
    • Identification of Trop-2 as an oncogene and an attractive therapeutic target in colon cancers
    • &, –
    • Wang J., Day R., Dong Y., Weintraub S.J. & Michel L. (2008) Identification of Trop-2 as an oncogene and an attractive therapeutic target in colon cancers. Mol. Cancer Ther. 7, 280–285.
    • (2008) Mol. Cancer Ther. , vol.7 , pp. 280-285
    • Wang, J.1    Day, R.2    Dong, Y.3    Weintraub, S.J.4    Michel, L.5
  • 36
    • 84872817120 scopus 로고    scopus 로고
    • Potential therapeutic target and independent prognostic marker of TROP2 in laryngeal squamous cell carcinoma
    • Wu H., Xu H., Zhang S. et al. (2013) Potential therapeutic target and independent prognostic marker of TROP2 in laryngeal squamous cell carcinoma. Head Neck 35, 1373–1378.
    • (2013) Head Neck , vol.35 , pp. 1373-1378
    • Wu, H.1    Xu, H.2    Zhang, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.